National Hospital-Supply Distribution Recovery Leader — Medical Consumables

The mandate

A national contract transition moved demand and inventory before hospital consumption, substitution approvals and regional replenishment rules were reconciled. Some hubs hold months of slow stock while critical consumables are expedited repeatedly to the same facilities. The distribution executive left after a shortage review found that fill rate counted unapproved substitutes and split orders that clinical users could not safely consume.

The interim starts within ten days for thirteen months, taking national distribution authority through inventory rebalance, two tender waves, seasonal demand and permanent succession. The first forty-five days establish item, hospital, consumption and usable-stock truth; later phases reset allocation and replenishment. Permanent recruitment begins in month six, with eight weeks of paired shortage command and two surprise product holds before handover.

Handover requires product and substitution identity, hospital demand signals, usable inventory, allocation tiers, replenishment clocks, regional buffers, transport capacity, Quality holds and customer communication. Completion is demonstrated when the successor absorbs a manufacturer shortage and national product hold, maintaining critical supply and evidence without unapproved substitution, hidden backorder or interim intervention.

The leader may reallocate released stock, reserve transport and hub capacity, freeze unsupported substitute use, adjust replenishment, invoke approved emergency sourcing, replace recovery leads and release SAR520 million of authorised supply spend. Clinical substitution, product release, tender award, contract amendment, permanent workforce action and write-off above delegation require accountable approval.

Clinical protocols, product selection, reimbursement, tender scoring, manufacturing, regulatory reporting and replacement of enterprise systems are excluded. The interim cannot treat an unapproved substitute as fulfilment, move held stock, inflate availability with expired or reserved inventory, prioritise influential hospitals outside approved tiers or pressure Quality. Every emergency allocation must retain patient-service and financial lineage.

Why this seat is open

The former executive departed when customer evidence showed that headline fill rate overstated clinically usable delivery after the contract transition. Temporary national authority is needed because essential supplies cannot wait for permanent recruitment or another tender cycle.

What you will own

• Reconcile item-level demand, consumption, substitution status, released stock, expiry, reservation and hospital backorder.
• Decide national allocation and replenishment inside approved criticality, Quality and customer-policy boundaries.
• Rebalance five regional hubs using consumption, lead time, expiry, shortage and transport evidence.
• Establish emergency-source and substitute handoffs with accountable clinical, Quality and procurement decisions.
• Govern fill-rate reporting around usable complete demand rather than lines, splits or unapproved alternatives.
• Command six scenarios involving manufacturer loss, product hold, hub outage, transport shortage and demand surge.
• Transfer authority after the successor independently resolves two compound national shortage events involving supplier constraint, product hold, hospital escalation and regional transport failure.

Candidate qualifications

• Held national healthcare, medical-device or critical-consumables distribution authority across hospital networks.
• Recovered supply after tender, distributor or contract transitions disrupted inventory and demand ownership.
• Allocated scarce released stock without assuming clinical substitution or Quality disposition authority.
• Rebalanced expiry-sensitive inventory across regional hubs using true hospital consumption and criticality.
• Managed public-sector customers, suppliers, transport and procurement under sustained shortage pressure.
• Transferred national shortage command through product hold and manufacturer-loss scenarios successfully, with evidence-based clinical priority, substitution governance and allocation appeals.

Non-negotiables

• Available within ten days for Riyadh residence, regional rotations and six shortage exercises.
• Direct hospital-supply distribution command is required; healthcare procurement alone is insufficient.
• Will disclose manufacturers, distributors, hospitals, tender advisers, carriers and healthcare investors.
• Will not approve substitutions, release products, score tenders, favour hospitals or conceal backorders.

1. 49 words maximum. Describe a hospital fill-rate measure that overstated clinically usable fulfilment.
2. 49 words maximum. How did you allocate scarce consumables without making clinical substitution decisions?
3. 49 words maximum. State your Riyadh availability and the largest hospital network you supplied.